Found 13 matching trials
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment N/A This is a prospective, non-interventional, observational study evaluating t...
Show More Location
Zhongshan Hospital, Fudan University
Learn More & Join Trial
Study of IBI343 in Subjects With Advanced Gastric/Gastroesophageal Junction Adenocarcinoma PHASE2 The goal of this clinical trial\] is toevaluate the safety, tolerability an...
Show More Location
Multiple Locations
Learn More & Join Trial
Efficacy and Safety of IBI110 Single Agent and in Combination With Sintilimab in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma (r/r DLBCL) PHASE1 The purpose of this study is to determine whether treatment with IBI110 sin...
Show More Location
Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine
Learn More & Join Trial
Sintilimab Combined With Tafolecimab and Chemotherapy as First-Line Treatment for Extensive-Stage Small Cell Lung Cancer PHASE2 This is a single arm, multi-center clinical trial. The goal of this clinica...
Show More Location
Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University
Learn More & Join Trial
TACE in Combination With PD-1/PD-L1 Inhibitors and Molecular Target Therapies for Advanced HCC N/A The purpose of this study is to evaluate the safety and efficacy of transar...
Show More Learn More & Join Trial
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT PHASE2 The goal of this single-arm, prospective clinical trial is to evaluate the ...
Show More Location
West China Hospital
Learn More & Join Trial
Multimodal AI for Predicting Response to Neoadjuvant Immunotherapy in Gastric Cancer (PRISM-GC) N/A Gastric cancer is a major global health challenge. Currently, a combination...
Show More Location
The Fifth Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC N/A Fruquintinib with PD-1 inhibitors (FP) and TAS-102 with bevacizumab (TB) ar...
Show More Location
Hunan Cancer hospital
Learn More & Join Trial
125I Seed Brachytherapy Combined With Immunotherapy for Primary, Recurrent, or Metastatic Malignant Tumors PHASE2 This prospective randomized trial evaluates the efficacy and safety of comb...
Show More Location
The 960th Hospital of People's Liberation Army (PLA)
Learn More & Join Trial
Synergistic Effects of PD-1 Antibody and Chemotherapy/Targeted Therapy Followed by Surgery-centric Local Treatment in Patients With Limited-metastatic Gastric Cancer PHASE2 ROSETTE trial is an open-label, randomized phase II study designed to inves...
Show More Location
Zhongshan Hospital Fudan University
Learn More & Join Trial